How Your Lymphatic System Keeps You Healthy: Must-Know Facts!

Pallavi Madhiraju- July 20, 2024 0

The lymphatic system forms an extensive network throughout our body and is crucial for maintaining fluid balance and immune function. Comprising lymph, lymph vessels, and ... Read More

The comprehensive health benefits of Turmeric: A deep dive

Pallavi Madhiraju- March 9, 2024 0

Turmeric, often hailed as the "Queen of Spices," holds a revered place not just in culinary traditions worldwide but also in the annals of medicinal ... Read More

Akthelia Pharmaceuticals gets EU Horizon Grant for IN-ARMOR project

Raghuram Kadari- April 19, 2023 0

Akthelia Pharmaceuticals, a preclinical drug development startup, and the University of Iceland have jointly secured a €6 million EU Horizon Grant for the IN-ARMOR project. ... Read More

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

Pallavi Madhiraju- March 17, 2023 0

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More

FDA approves Janssen’s TECVAYLI for multiple myeloma treatment

Pallavi Madhiraju- October 27, 2022 0

The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration's approval of its first bispecific T-cell engager antibody, ... Read More

Blender Bites launches Daily Defen-C superfood smoothie

Pallavi Madhiraju- October 16, 2022 0

Blender Bites, a Canadian manufacturer of organic and plant-based frozen functional foods, has launched a new superfood smoothie innovation called Daily Defen-C. According to Blender ... Read More

BriaCell Therapeutics gets license for anti-cancer agent sCD80 from UMBC

pallavi123- August 6, 2022 0

BriaCell Therapeutics has signed an exclusive licensing deal with the University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a ... Read More

Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn

pallavi123- August 27, 2021 0

US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company, for $18.5 per share or $2.26 billion ... Read More

Zydus Cadila gets EUA for ZyCoV-D vaccine for Covid-19 in India

pallavi123- August 20, 2021 0

Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine ... Read More

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

pallavi123- March 30, 2021 0

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe ... Read More